Heron Therapeutics, Inc. (0J4V.L) LSE

1.29

-0.0714(-5.25%)

Updated at December 24 03:27PM

Currency In USD

Valuation

Market Cap230.2M
Enterprise Value382.16M
P/E Ratio-211.76
PEG Ratio-2.4
Price/Sales Ratio1.35
Price/Book Ratio-7.23
Enterprise/Revenue2.42
Enterprise/EBITDA52.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.01
Operating Margin0.01

Management Effectiveness

Return On Assets-0
Return On Equity0.03

Income Statement

Revenue144.29M
Revenue/Share0.97
Gross Profit105.64M
EBITDA-5.06M
Net Income-13.58M
Diluted EPS-0.09

Balance Sheet

Total Cash55.49M
Total Cash/Share0.26
Total Debt140.44M
Total Debt/Equity-6.48
Current Ratio0.82
Book Value Per Share-0.18

Price History

52-Week Change-16.32
52-Week High3.2
52-Week Low0.54
Moving Average 50 Days2.41
Moving Average 200 Days1.57

Statistics

Average Volume12,412
Shares Outstanding157.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A